1
|
Savill M, Loewy RL, Niendam TA, Porteus AJ, Rosenthal A, Gobrial S, Meyer M, Bolden KA, Lesh TA, Ragland JD, Carter CS. The diagnostic accuracy of screening for psychosis spectrum disorders in behavioral health clinics integrated into primary care. Schizophr Res 2024; 266:190-196. [PMID: 38422889 DOI: 10.1016/j.schres.2024.02.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/25/2023] [Revised: 01/29/2024] [Accepted: 02/10/2024] [Indexed: 03/02/2024]
Abstract
Screening for psychosis spectrum disorders in primary care could improve early identification and reduce the duration of untreated psychosis. However, the accuracy of psychosis screening in this setting is unknown. To address this, we conducted a diagnostic accuracy study of screening for psychosis spectrum disorders in eight behavioral health services integrated into primary care clinics. Patients attending an integrated behavioral health appointment at their primary care clinic completed the Prodromal Questionnaire - Brief (PQ-B) immediately prior to their intake assessment. This was compared to a diagnostic phone interview based on the Structured Interview for Psychosis Risk Syndromes (SIPS). In total, 145 participants completed all study procedures, of which 100 screened positive and 45 negative at a provisional PQ-B threshold of ≥20. The PQ-B was moderately accurate at differentiating psychosis spectrum from no psychosis spectrum disorders; a PQ-B distress score of ≥27 had a sensitivity and specificity of 71.2 % and 57.0 % respectively. In total, 66 individuals (45.5 %) met criteria for a psychosis spectrum disorder and 24 (16.7 %) were diagnosed with full psychosis, indicating a high prevalence of psychosis in the sample. Overall, screening for psychosis spectrum disorders in an IBH primary care setting identified a relatively high number of individuals and may identify people that would otherwise be missed. The PQ-B performed slightly less well than in population-based screening in community mental health settings. However, the findings suggest this may represent an effective way to streamline the pathway between specialty early psychosis programs and primary care clinics for those in need.
Collapse
Affiliation(s)
- Mark Savill
- University of California, Davis, United States of America.
| | - Rachel L Loewy
- University of California, San Francisco, United States of America
| | - Tara A Niendam
- University of California, Davis, United States of America
| | | | - Adi Rosenthal
- University of California, Davis, United States of America
| | - Sarah Gobrial
- University of California, Davis, United States of America
| | - Monet Meyer
- University of California, Davis, United States of America
| | | | - Tyler A Lesh
- University of California, Davis, United States of America
| | | | | |
Collapse
|
2
|
Meyer MS, Rosenthal A, Bolden KA, Loewy RL, Savill M, Shim R, Rodriguez J, Flores V, Pavao E, Niendam TA. Psychosis screening in schools: Considerations and implementation strategies. Early Interv Psychiatry 2020; 14:130-136. [PMID: 31287611 DOI: 10.1111/eip.12858] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/11/2018] [Revised: 03/07/2019] [Accepted: 06/09/2019] [Indexed: 11/26/2022]
Abstract
AIM Duration of untreated psychosis, or the time between onset of psychosis symptoms and accurate diagnosis and treatment, is a significant predictor of both initial treatment response and long-term outcomes. As such, efforts to improve rapid identification are key. Because early signs of psychosis commonly emerge in adolescence, schools have the potential to play an important role in the identification of psychosis-spectrum disorders. METHODS To illustrate the potential role of schools in this effort, the current paper describes implementation of a psychosis screening tool as part of a larger study focused on reducing the duration of untreated psychosis in Sacramento, CA. RESULTS Clinical considerations related to screening for psychosis in schools, including ethical concerns, logistics, screening population and stigma are addressed. Implementation strategies to address these concerns are suggested. CONCLUSIONS Early psychosis screening in the school system could improve early identification, reduce stigma and may represent an important further step towards an integrative system of mental health.
Collapse
Affiliation(s)
- Monet S Meyer
- Department of Psychiatry, University of California, Davis, Sacramento, California
| | - Adi Rosenthal
- Department of Psychiatry, University of California, Davis, Sacramento, California
| | - Khalima A Bolden
- Department of Psychiatry, University of California, Davis, Sacramento, California
| | - Rachel L Loewy
- Department of Psychiatry, University of California, San Francisco, San Francisco, California
| | - Mark Savill
- Department of Psychiatry, University of California, San Francisco, San Francisco, California
| | - Ruth Shim
- Department of Psychiatry, University of California, Davis, Sacramento, California
| | | | - Victoria Flores
- Sacramento City Unified School District, Sacramento, California
| | - Earl Pavao
- Natomas Unified School District, Sacramento, California
| | - Tara A Niendam
- Department of Psychiatry, University of California, Davis, Sacramento, California
| |
Collapse
|
3
|
Mayo D, Bolden KA, Simon TJ, Niendam TA. Bullying and psychosis: The impact of chronic traumatic stress on psychosis risk in 22q11.2 deletion syndrome - a uniquely vulnerable population. J Psychiatr Res 2019; 114:99-104. [PMID: 31054456 PMCID: PMC6564673 DOI: 10.1016/j.jpsychires.2019.04.011] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/11/2018] [Revised: 04/04/2019] [Accepted: 04/11/2019] [Indexed: 01/05/2023]
Abstract
Bullying is an adverse childhood experience that is more common among youth with special needs and is associated with increased psychopathology throughout the lifespan. Individuals with chromosome 22q11.2 deletion syndrome (22q) represent one group of special needs youth who are at increased risk for bullying due to co-occurring genetically-mediated developmental, physical, and learning difficulties. Furthermore, individuals with 22q are at increased risk for developing psychotic disorders such as schizophrenia. However, there is a paucity of research exploring the impact of bullying on individuals with 22q and the possible impact this has on risk for psychosis in this population. To explore this relationship using existing research the goals of the review are: (i) to explore the nature of bullying among youth with special needs, and (ii) to discuss its potential role as a specific risk factor in the development of adverse outcomes, including psychosis symptoms. We reviewed the relationship between bullying and its short and long-term effects on the cognitive, social, and developmental functioning of typically developing individuals and those with special needs. We propose an interactive relationship between trauma, stress, and increased psychosis risk among youth with 22q with a history of bullying. The early childhood experience of trauma in the form of bullying promotes an altered developmental trajectory that may elevate the risk for maladaptive functioning and subsequent psychotic disorders, particularly in youth with genetic vulnerabilities. Therefore, we conclude the experience of bullying among individuals with 22q should be more closely examined.
Collapse
Affiliation(s)
- Danessa Mayo
- Department of Psychiatry and Behavioral Sciences, Imaging Research Center, USA; Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California, Davis, Sacramento, CA, USA
| | - Khalima A Bolden
- Department of Psychiatry and Behavioral Sciences, Imaging Research Center, USA.
| | - Tony J Simon
- Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California, Davis, Sacramento, CA, USA
| | - Tara A Niendam
- Department of Psychiatry and Behavioral Sciences, Imaging Research Center, USA
| |
Collapse
|
4
|
Cattie J, Marquine MJ, Bolden KA, Obermeit LC, Morgan EE, Franklin DR, Umlauf A, Beck JM, Atkinson JH, Grant I, Woods SP. Predictors of Attrition in a Cohort Study of HIV Infection and Methamphetamine Dependence. J Subst Use 2015; 20:407-416. [PMID: 26752974 DOI: 10.3109/14659891.2014.942397] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Longitudinal cohort studies of HIV and substance use disorders play an important role in understanding these conditions, but high rates of attrition can threaten their integrity and generalizability. This study aimed to identify factors associated with attrition in a 5-year observational cohort study of 469 individuals with and without HIV infection and methamphetamine (MA) dependence. Rates of attrition in our four study groups were approximately 24% in HIV-MA-, 15% in HIV+MA-, 56% in HIV-MA+, and 47% in HIV+MA+ individuals. Predictors of attrition in the overall cohort included history of MA, alcohol, and other substance dependence, learning impairment, reduced cognitive reserve, and independence in activities of daily living (all ps < .05), but varied somewhat by clinical group. Of particular note, enrollment in a neuroimaging substudy was associated with significantly boosted rates of retention in the MA groups. Results from this investigation highlight the complexity of the clinical factors that influence retention in cohort studies of HIV-infected MA users and might guide the development and implementation of targeted retention efforts.
Collapse
Affiliation(s)
- J Cattie
- San Diego State University/University of California, San Diego Joint Doctoral Program in Clinical Psychology; San Diego, California, USA
| | - M J Marquine
- Department of Psychiatry, University of California, San Diego; San Diego, California, USA
| | - K A Bolden
- San Diego State University/University of California, San Diego Joint Doctoral Program in Clinical Psychology; San Diego, California, USA
| | - L C Obermeit
- San Diego State University/University of California, San Diego Joint Doctoral Program in Clinical Psychology; San Diego, California, USA
| | - E E Morgan
- Department of Psychiatry, University of California, San Diego; San Diego, California, USA
| | - D R Franklin
- Department of Psychiatry, University of California, San Diego; San Diego, California, USA
| | - A Umlauf
- Department of Psychiatry, University of California, San Diego; San Diego, California, USA
| | - J M Beck
- Department of Psychiatry, University of California, San Diego; San Diego, California, USA
| | - J H Atkinson
- Department of Psychiatry, University of California, San Diego; San Diego, California, USA; Psychiatry Service, San Diego VA Healthcare System; San Diego, California, USA
| | - I Grant
- Department of Psychiatry, University of California, San Diego; San Diego, California, USA
| | - S P Woods
- Department of Psychiatry, University of California, San Diego; San Diego, California, USA
| | | |
Collapse
|